ライフサイエンスコーパス: intensive care unit

1 act treatment of up to 4% of children in the intensive care unit.

2 %; 37/50) were critically ill and treated on intensive care unit.

3 hospitalized, 20 (40.8%) were admitted to an intensive care unit.

4 in the 25 of 35 of those discharged from the intensive care unit.

5 ventilator support and 18% were admitted to intensive care unit.

6 e unit as an instrument for admission to the intensive care unit.

7 and neurologic status at discharge from the intensive care unit.

8 ysiological patterns, a critical task in the intensive care unit.

9 s a clinically useful tool on the Paediatric Intensive Care unit.

10 tivisceral transplant recipients in a single intensive care unit.

11 as a clinical tool in a tertiary Paediatric Intensive Care unit.

12 xaemia, with 67% requiring management in the intensive care unit.

13 dings during the baby's stay in the Neonatal Intensive Care Unit.

14 % were >=65 years old, and 66.1% were in the intensive care unit.

15 bility the patient was admitted to the local Intensive Care Unit.

16 dure severely limits its application outside intensive care units.

17 stress syndrome requiring prolonged stays in intensive care units.

18 igh morbidity among patients discharged from intensive care units.

19 ections represent a major burden in neonatal intensive care units.

20 COVID-19, especially in patients admitted to intensive care units.

21 s more than half of patients discharged from intensive care units.

22 istome persist after discharge from neonatal intensive care units.

23 tion, is an increasing cause of morbidity in intensive care units.

24 ts (67.6%) were ordered in hospital wards or intensive care units.

25 ators to implement family-centered rounds in intensive care units.

26 ken drastic measures to avoid an overflow of intensive care units.

27 cally ill patients with COVID-19 from 208 UK intensive care units.

28 and respiratory failure across 34 pediatric intensive care units 11/2008-5/2016.

29 r oxygen administration, 18 were admitted to intensive care units, 12 required invasive ventilation,

30 (n=493), Early Infection (n=200), St Paul's Intensive Care Unit 2 (n=203), and Vasopressin Versus No

31 presentation and a higher admission rate in intensive care units (20 of 20 patients [100%] vs 12 of

32 42.0-144.0 h; p < 0.01), and shorter stay in intensive care unit (3.9, 3.0-7.0 vs 7.7, 5.0-15.0 d; p

33 34% were female; and 57% were from neonatal intensive care units, 33% were from pediatric intensive

34 ls (60.3% vs 39.7%), from facilities without intensive care unit (46.9% vs 22.4%) or interventional r

35 more often on general medicine wards than in intensive care units (46% versus 33%; 19% versus 60% in

36 % Hispanic/Latinx; 23.4% Black; 20.1% in the intensive care unit; 46.8% receiving supplemental oxygen

37 these 186 patients, 27% were admitted to the intensive care unit, 48% were immunocompromised, and 45%

38 ospital-acquired pneumonia (HAP) outside the intensive care unit, 61% were treated empirically withou

39 epresented an ill population with 69% in the intensive care unit, 63% mechanically ventilated, and 42

40 A case study focusing on intensive care unit-acquired bacteremia using data from

41 arch Council score; reduced the incidence of intensive care unit-acquired weakness and intensive care

42 an 2,000 patient samples were collected from intensive care units across nine hospitals and tested fo

43 had similar rates of admission (89% vs 90%), intensive care unit admission (35% vs 36%), intubation (

44 e clinical course, including higher rates of intensive care unit admission (69%), intubation (65%), r

45 mall for gestational age (SGA), and neonatal intensive care unit admission (NICUa) associated with ga

46 monia (OR = 2.7; 95% CI, 2.2-3.2; P < .001); intensive care unit admission (OR = 1.3; 95% CI, 1.0-1.7

47 Ninety percent of patients required intensive care unit admission and 39% were intubated.

48 performed in patients upon hospital ward or intensive care unit admission and in healthy controls (n

49 nd the log-rank test, we compared morbidity (intensive care unit admission and intubation) and mortal

50 fibrillation and delirium occurring between intensive care unit admission and the earlier of postope

51 Secondary outcomes included risk of intensive care unit admission and ventilation in hospita

52 nt of CT lung abnormality were predictors of intensive care unit admission or death.

53 Secondary outcomes were intensive care unit admission rates, central venous cath

54 Intensive care unit admission was required for 27 patien

55 o predict critical illness (ie, death and/or intensive care unit admission with invasive ventilation)

56 tcomes attributable to CDI, including death, intensive care unit admission, and colectomy, were obser

57 hree groups: routine inward hospitalization, intensive care unit admission, and deceased based on a s

58 genital heart disease, chronic lung disease, intensive care unit admission, and ventilator use) were

59 iness of antiviral use, hospitalization, and intensive care unit admission, but no significant differ

60 advanced medical outcomes (hospitalization, intensive care unit admission, intubated mechanical vent

61 advanced medical outcomes (hospitalization, intensive care unit admission, intubated mechanical vent

62 primary outcome was clinical deterioration (intensive care unit admission, invasive mechanical venti

63 site adverse clinical outcome of intubation, intensive care unit admission, or death.

64 need for vasopressor, incidence of unplanned intensive care unit admission, rate of need for rapid re

65 tion, blood was collected within 72 hours of intensive care unit admission.

66 a median of 2 days (Q1, Q3: 1, 3 days) from intensive care unit admission.

67 ransfusion was administered within 7 days of intensive care unit admission.

68 Intensive care unit admissions increased for RSVH (from

69 o experience high rates of hospitalizations, intensive care unit admissions, and in-hospital deaths a

70 -related mortality; length of hospital stay; intensive care unit admissions; acute graft-versus-host

71 y outcomes included duration of ventilation, intensive care unit and hospital length of stay (LOS), 3

72 y outcomes included duration of ventilation, intensive care unit and hospital length of stay, 3-month

73 hospital mortality was 19.0%, and the median intensive care unit and hospital lengths of stay were 2.

74 tubation among patients extubated after SBT; intensive care unit and hospital lengths of stay; and ho

75 s within 14 days after surgery, durations of intensive care unit and hospital stays, and all-cause mo

76 t to critically ill patients confined to the intensive care unit and is characterized by colonization

77 Most patients required management in the intensive care unit and steroid therapy.

78 blood products donated, limited space in the intensive care unit and the duty to maintain safety and

79 in vegetative state, was transferred to the intensive care unit and then to the Health and Care Cent

80 ntly more likely to have been admitted to an intensive care unit and to have received an intensive pr

81 on use and intensive treatment (admission to intensive care unit and/or positive pressure ventilation

82 id clinical deterioration, prolonged stay in intensive care units and high risk for mortality correla

83 ificant differences with respect to stays in intensive care units and hospitals.

84 cal workflows and improved patient safety in intensive care units and operating rooms.

85 nfection, 11 had been hospitalized (3 in the intensive care unit) and 15 had died (mortality, 26%).

86 f mechanical ventilation and/or admission to intensive care unit) and development of recurrent wheeze

87 required admission, with 18 admitted to the intensive care unit, and 13 requiring intubation.

88 tile range, 1-5), 14.5% were admitted to the intensive care unit, and 15.9% received oseltamivir.

89 ence of myocarditis, 80% were admitted to an intensive care unit, and 2 died.

90 four cases (64.1%) required admission to the intensive care unit, and 28 (52.8%) had mechanical venti

91 Thirty patients were admitted to the intensive care unit, and 30 patients died during the hos

92 hose hospitalized, 47.5% were admitted to an intensive care unit, and 6.2% died during hospitalizatio

93 those with CAP (138 of 722) admitted to the intensive care unit, and 61% of those (138 of 225) with

94 h increased risk of complications, length of Intensive Care Unit, and overall hospital stay.

95 Most patients were hospitalized, 12.1% in intensive care units, and 17.6% needed ventilator suppor

96 ntensive care units, 33% were from pediatric intensive care units, and 9% were from other hospital wa

97 ospitals lack incinerators, pretested blood, intensive care units, and computed tomography, respectiv

98 This study used bed availability in the intensive care unit as an instrument for admission to th

99 r life-threatening COVID-19, with 66% in the intensive care unit, as part of the US FDA expanded acce

100 irus disease 2019 (COVID-19) admitted to the intensive care unit at a public hospital in Washington S

101 Admission to intensive care unit at listing was associated with poore

102 Two equivalent "Level III" neonatal intensive care units at the University Hospital Vienna,

103 atient-level data including mortality rates, intensive care unit bed days, and ventilator days from i

104 d to the fraught question of how to allocate intensive care unit beds and mechanical ventilators if t

105 triage of patients to the limited number of intensive care unit beds or facilities.

106 ury prevention methods in place, being in an intensive care unit, being in a smaller hospital, and be

107 o Cambridge University Hospital's Paediatric Intensive Care Unit between January 2009 and December 20

108 s the incidence of bloodstream infections in intensive care units, but its effect has been understudi

109 eases incidence of bloodstream infections at intensive care units, but its effect has been understudi

110 ts with DoC and that detection of CMD in the intensive care unit can predict functional recovery at 1

111 He did not require intensive care unit care or ventilation.

112 R, 56-78]; 33.5% female) were treated in the intensive care unit care, 320 (12.2%) received invasive

113 roblem that threatens patients' treatment in intensive care units, causing thousands of deaths and a

114 Cardiac intensive care unit (CICU) patients <=18 years of age me

115 ss the spectrum of shock severity in cardiac intensive care unit (CICU) patients.

116 studies have examined this metric in cardiac intensive care unit (CICU) patients.

117 y the SCAI shock classification in a cardiac intensive care unit (CICU) population.

118 Contemporary cardiac intensive care units (CICUs) have an increasing prevalen

119 Clinical investigations of shock in cardiac intensive care units (CICUs) have primarily focused on a

120 r disease are frequently admitted to cardiac intensive care units (CICUs), where care is commensurate

121 uded family appreciation and a collaborative intensive care unit culture committed to dignity-conserv

122 tissue sampling in 126 (11%) of the neonatal intensive care unit deaths.

123 l fractures were assessed at baseline (after intensive care unit discharge) and at 6 and 12 months.

124 ation with worse outcomes in patients in the intensive care unit, discuss potential biologically plau

125 The 68-year-old male was admitted to the intensive care unit due to severe community acquired pne

126 ) which is currently a growing challenge for intensive care units due to the outbreak of the COVID-19

127 y patients receive non-beneficial care in US intensive care units during their final months of life.

128 ven that less than one-third of all neonatal intensive care units follow Mexican National ROP guideli

129 The combined intensive care unit group and deceased patients had sign

130 erm infants exposed to music in the neonatal intensive care units have significantly increased coupli

131 ays in the hospital (5 vs 15.5 days), in the intensive care unit (ICU) (4 vs 12 days), and on mechani

132 Mortality (22% vs 17%, P > .05) and intensive care unit (ICU) admission (26% vs 12%, P > .05

133 n for predicting patient outcome in terms of intensive care unit (ICU) admission (AUC: 0.75 vs 0.68)

134 R], 1.03 per year of increase; P = .001) and intensive care unit (ICU) admission (OR, 17.3; P < .001)

135 ll-cause death, severe Covid-19 diagnosis or intensive care unit (ICU) admission for men versus women

136 Limited data exist on predictors of intensive care unit (ICU) admission in patients with hem

137 Adverse outcome was defined as intensive care unit (ICU) admission or death.

138 patterns in the plasma of septic patients at intensive care unit (ICU) admission predicted persistent

139 nfirmed COVID-19 diagnosis, hospitalization, intensive care unit (ICU) admission, and death.

140 tal mortality, need for ventilatory support, intensive care unit (ICU) admission, and length of stay.

141 were more likely to be hospitalized, require intensive care unit (ICU) admission, and receive oxygen

142 hospitalization: general floor care without intensive care unit (ICU) admission, invasive respirator

143 outcome, defined as a composite endpoint of intensive care unit (ICU) admission, mechanical ventilat

144 Pooled rates of intensive care unit (ICU) admission, mortality, and acut

145 We assessed hospitalization risk, intensive care unit (ICU) admission, need for oxygen sup

146 patients after a median of 4 (2-8) days from intensive care unit (ICU) admission.

147 ng 2 cases of megacolon, 1 colectomy, and 22 intensive care unit (ICU) admissions.

148 ients with coma who had been admitted to the intensive care unit (ICU) after resuscitation from cardi

149 acquirers without a direct admission to the intensive care unit (ICU) and 11.4% in importers and 11.

150 ients with disorders of consciousness in the intensive care unit (ICU) and found that covert consciou

151 cterized by prolonged duration of stay in an intensive care unit (ICU) and increased number of leukoc

152 me to extubation, time to discharge from the intensive care unit (ICU) and one-year survival.

153 Hospital inpatient and intensive care unit (ICU) bed shortfalls may arise due t

154 60-day period, analyzed for their effects on intensive care unit (ICU) demand and death rate, and com

155 ments in terms of mortality and hospital and intensive care unit (ICU) discharge rates.

156 age <35 years) brother pairs admitted to the intensive care unit (ICU) due to severe COVID-19.

157 Patients admitted to the intensive care unit (ICU) for COVID-19-related acute res

158 at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascu

159 ction and inflammation and long term stay in intensive care unit (ICU) in hospitals.

160 9.9 days, p = 0.028) and shorter duration of intensive care unit (ICU) length of stay (LOS) prior to

161 nd outcomes analysis, including hospital and intensive care unit (ICU) length of stay, invasive mecha

162 g a diary for patients while they are in the intensive care unit (ICU) might reduce their posttraumat

163 are undergoing mechanical ventilation in the intensive care unit (ICU) often receive a high fraction

164 rmed COVID-19 were identified in the medical intensive care unit (ICU) or a specialised non-ICU COVID

165 (n = 200) from emergency department (ED) and intensive care unit (ICU) patients at a tertiary care ac

166 er number of perforin-expressing NK cells in intensive care unit (ICU) patients compared with non-ICU

167 Intensive care unit (ICU) patients or patients requiring

168 Vasopressors are commonly administered to intensive care unit (ICU) patients to raise blood pressu

169 We assayed EBV from the plasma of intensive care unit (ICU) patients with sepsis due to co

170 ions causing a high mortality rate mainly in intensive care unit (ICU) patients.

171 sociated infections (HAIs), particularly for intensive care unit (ICU) patients.

172 placement therapy (CRRT) represent a growing intensive care unit (ICU) population.

173 Use of intensive care unit (ICU) resources in the USA far outpa

174 r pediatric resident physicians during their intensive care unit (ICU) rotations: extended-duration w

175 s, or hospitalization >24 hours), or severe (intensive care unit (ICU) stay for >24 hours, septic sho

176 ior studies of patient survivorship after an intensive care unit (ICU) stay suggest that many critica

177 markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly defin

178 first 10 days in relation to their need for intensive care unit (ICU) treatment.

179 The effects of intensive care unit (ICU) visiting hours remain uncertai

180 ttle-area hospitals who were admitted to the intensive care unit (ICU) with confirmed infection with

181 In the intensive care unit (ICU), 30.9% (CI, 29.7% to 32.2%) of

182 perglycaemia is one such complication in the intensive care unit (ICU), accompanied by decades of con

183 first extubation, time to discharge from the intensive care unit (ICU), and 1-year survival.

184 endpoint of escalation of care from ward to intensive care unit (ICU), new requirement for mechanica

185 ator-associated pneumonia is the most common intensive care unit (ICU)-acquired infection, yet accura

186 The national impact on intensive care unit (ICU)-acquired infections has not be

187 tive disease incidence and mortality, and on intensive care unit (ICU)-bed occupancy.

188 oeconomic and clinical risk factors for post-intensive care unit (ICU)-related long-term cognitive im

189 tient management, with 7 (50%) placed in the intensive care unit (ICU).

190 ne profile of critically ill patients in the intensive care unit (ICU).

191 nt postextubation respiratory failure in the intensive care unit (ICU).

192 33 (55%) of 60 were admitted to an intensive care unit (ICU).

193 ntilation and delirium among patients in the intensive care unit (ICU).

194 0% of acute kidney injury (AKI) cases in the intensive care unit (ICU).

195 pitalized and 26.8% (n = 30) admitted to the intensive care unit (ICU).

196 nts as stress ulcer prophylaxis drugs in the intensive care unit (ICU).

197 n due to the lack of an available bed in the intensive care unit (ICU).

198 on ventilation and the length of stay in the intensive care unit (ICU).

199 Patients in the intensive care units (ICU) had significantly higher CEC

200 d critically unwell patients admitted to the intensive care unit [ICU; n=5]).

201 eters and CT metrics versus patient outcome (intensive care unit [ICU] admission or death vs no ICU a

202 care, and hospital outcomes (length of stay, intensive care unit [ICU] admission, mechanical ventilat

203 d hospitalization outcomes (severe COVID-19, intensive care unit [ICU] admission, mechanical ventilat

204 757 (15.5%) included UAT performed (18.4% of intensive care unit [ICU] and 15.3% of non-ICU patients)

205 iorates while they are in wards (outside the intensive care unit [ICU]) have considerable morbidity a

206 its did not decrease significantly (surgical intensive care unit [ICU], P = 0.06; surgical units, P =

207 , we investigated DNR orders on admission to intensive care units (ICUs) among 106,873 patients in th

208 ings were analyzed separately in patients in intensive care units (ICUs) and other departments (non-I

209 tically ill adults with COVID-19 admitted to intensive care units (ICUs) at 67 hospitals across the U

210 th laboratory-confirmed COVID-19 admitted to intensive care units (ICUs) at 68 hospitals across the U

211 hort study enrolling patients admitted in 55 intensive care units (ICUs) for PF from 2010 to 2016.

212 cquired bacteremia using data from 2 general intensive care units (ICUs) from 2 London teaching hospi

213 Extensive monitoring in intensive care units (ICUs) generates large quantities o

214 , open-label, clinical trial conducted in 41 intensive care units (ICUs) in Brazil.

215 boratory-confirmed influenza hospitalized in intensive care units (ICUs) in Greece over 8 seasons (20

216 er 26, 2017, through December 17, 2019, in 8 intensive care units (ICUs) in the Netherlands among 980

217 or reducing P. aeruginosa (Pa) infections in intensive care units (ICUs) remains questioned.

218 Hospital beds, intensive care units (ICUs), and ventilators are vital f

219 In five intensive care units (ICUs), we enrolled conscious, crit

220 common procedure for patients especially in intensive care units (ICUs).

221 infants with diseases of unknown etiology in intensive care units (ICUs).

222 sociated urinary tract infection outcomes in intensive care units (ICUs).

223 cing recently became feasible for infants in intensive care units (ICUs).

224 for can improve the outcomes of patients in intensive care units (ICUs).

225 surgery and at the time of admission to the intensive care unit in critically ill patients.

226 dult patients with SD admitted to a tertiary intensive care unit in Malaysia.

227 lations were performed at the bedside in the intensive care unit in patients who had undergone a tria

228 a in children who were admitted to pediatric intensive care units in 14 centers for cardiogenic shock

229 -blind, parallel-group trial conducted at 74 intensive care units in 8 European countries (December 2

230 sed controlled trial was done in 18 neonatal intensive care units in England.

231 trial conducted in 36 level III/IV neonatal intensive care units in Europe among 1013 infants with b

232 ast 24 hours of mechanical ventilation at 18 intensive care units in Spain.

233 ed randomized trial conducted in 19 neonatal intensive care units in the Netherlands and Belgium from

234 lticentre cohort study across eight neonatal intensive care units in the UK and USA, recruiting term

235 (INHALE 1 and INHALE 2) done in 153 hospital intensive-care units in 25 countries.

236 ral examples of recent CRTs of community and intensive care unit infection prevention interventions a

237 ed early antibiotic exposure in the neonatal intensive care unit is associated with an increased risk

238 mized clinical trial at 16 Canadian neonatal intensive care units (June 2015-April 2018 with last inf

239 day mortality (7.1% vs 2.9%), shorter median intensive care unit length of stay (2 days vs 1 day) and

240 (in-hospital death, hospital length of stay, intensive care unit length of stay, and ventilator days)

241 , rate of need for rapid response team call, intensive care unit length of stay, hospital length of s

242 in donor selection (age, cold ischemia time, intensive care unit length, amylase concentration), panc

243 length of hospitalization, admission to the intensive care unit, length of oxygen support, and overa

244 sociation was noted between VL, admission to intensive care unit, length of oxygen support, and overa

245 macaques were maintained for 20 hours under intensive care unit-level conditions.

246 Posttransplant, overall, and intensive care unit LOS increased with increasing LAS.

247 antisepsis of healthcare workers in neonatal intensive care units may be associated with long working

248 stics and outcomes (length of stay, need for intensive care unit, mechanical ventilation, and in-hosp

249 Primary composite outcome (escalation to intensive care unit, mechanical ventilation, or in-hospi

250 that aimed to optimize BCx use in a medical intensive care unit (MICU) and five medicine units at a

251 erences in handgrip strength, delirium rate, intensive care unit mortality, hospital mortality, and p

252 ure or arrhythmias requiring admission to an intensive care unit, myocardial infarction, stroke, aort

253 for gestational age (SGA/LGA), and neonatal intensive care unit (NICU) admission.

254 Mothers with babies in the neonatal intensive care unit (NICU) face a host of challenges fol

255 ital sign monitoring systems in the neonatal intensive care unit (NICU) require multiple wires connec

256 h within 7 days or admission to the neonatal intensive care unit (NICU) with moderate-to-severe hypox

257 /USA100 clone among 18 infants in a neonatal intensive care unit (NICU).

258 h care-associated infections in the neonatal intensive care unit (NICU).

259 le for sepsis in preterm infants in neonatal intensive care units (NICUs) worldwide.

260 dard clinical care in neonatal and pediatric intensive-care units (NICUs and PICUs, respectively) inv

261 Randomisation was stratified by severity (in intensive care unit, not in intensive care but requiring

262 diagnosis of aSAH admitted to the neurologic intensive care unit of a regional referral hospital over

263 upon thermal images obtained in a pediatric intensive care unit of a tertiary care hospital.

264 The primary end point was admission to the intensive care unit or death during hospitalization, and

265 severe disease, defined as admission to the intensive care unit or death.

266 outcome, defined as: death, admission to an intensive care unit, or decision to withdraw or withhold

267 hemoglobin<9.5 g/dl in the operating room or intensive care unit, or if hemoglobin<8.5 g/dl on the no

268 creening examinations at a level IV neonatal intensive care unit over a 7-year period.

269 In the CIIN group, patients had longer intensive care unit (P = 0.024) and hospital (P = 0.008)

270 study assessing the risk of AKI in pediatric intensive care unit patients after exposure to vancomyci

271 e (UDP-Glc) was higher in urine samples from intensive care unit patients who developed AKI compared

272 n stool swab samples collected from neonatal intensive care unit patients within 7 days of discontinu

273 In non-intensive care unit patients, a 19% lower survival rate

274 Main outcomes were admission to pediatric intensive care unit (PICU) and length of hospital stay (

275 ctional, observational study, 145 paediatric intensive care units (PICUs) from 27 countries were recr

276 ess, appropriateness of empiric antibiotics, intensive care unit placement, tracheostomy dependence,

277 cohort of COVID-19 patients admitted to the intensive care unit, platelet-monocyte interaction was s

278 We included primary research in adult intensive care units regardless of patients' length of s

279 of intensive care unit-acquired weakness and intensive care unit-related complications such as ventil

280 ytotoxic lesions of the corpus callosum, and intensive care unit-related complications, we identified

281 The risk of admission to the intensive care unit (RR, 3.9; 95% CI, 3.4-4.5), need for

282 Covid-19 intensive care unit staff were relatively protected (0.4

283 Low FTR hospitals tended to have a closed intensive care unit staffing model (56% vs 20%, P < 0.00

284 uration of mechanical ventilation, length of intensive care unit stay and hospital stay.

285 er transplantation (LT), longer hospital and intensive care unit stay, higher incidence of infection

286 Pretransplant, dCLKT had longer intensive care unit stay, were more often intubated, and

287 dity, length of hospital stay, and length of intensive care unit stay.

288 ively predicting trauma patients who require intensive care unit stays longer than 5 days with ongoin

289 Among patients hospitalized in the intensive care unit, the case fatality is up to 40%.

290 espite the growing use of RRT in the cardiac intensive care unit, there are few resources for the car

291 ition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection,

292 is difficult to predict, and the capacity of intensive care units was a limiting factor during the pe

293 established, elective care was postponed and Intensive Care Units were augmented with equipment and m

294 criteria for ROP screening in three neonatal intensive care units were included in the study.

295 iridans sepsis, which required 4 days in the intensive care unit with antimicrobial and inotropic sup

296 ctive carriage study in a Cambodian neonatal intensive care unit with hyperendemic third-generation c

297 e rehabilitation of patients admitted to the intensive care unit, with a proven benefit for criticall

298 spitalized patients require admission to the intensive care unit, with the majority of those requirin

299 d family-centered care intervention in adult intensive care units, with limited evidence on the impac

300 ma and is present in ~10% of all patients in intensive care units worldwide.